PMID- 32424774 OWN - NLM STAT- MEDLINE DCOM- 20211006 LR - 20240226 IS - 1573-6830 (Electronic) IS - 0272-4340 (Linking) VI - 41 IP - 4 DP - 2021 May TI - Tetramethylpyrazine Protects Blood-Spinal Cord Barrier Integrity by Modulating Microglia Polarization Through Activation of STAT3/SOCS3 and Inhibition of NF-small ka, CyrillicB Signaling Pathways in Experimental Autoimmune Encephalomyelitis Mice. PG - 717-731 LID - 10.1007/s10571-020-00878-3 [doi] AB - We previously reported that tetramethylpyrazine (TMP) alleviates experimental autoimmune encephalomyelitis (EAE) by decreasing glia activation. Activated microglia has been shown to mediate blood-spinal cord barrier (BSCB) disruption, which is a primary and continuous pathological characteristic of multiple sclerosis (MS). Therefore, in this study, we further investigated whether TMP protects the BSCB integrity by inhibition of glia activation to alleviate EAE. Extravasation of evans blue was used to detect the BSCB disruption. Tumor necrosis factor-alpha (TNF-alpha)/interlukine-1beta (IL-1beta) and interlukine-4 (IL-4)/interlukine-10 (IL-10) were determined by enzyme-linked immunosorbent assay. BV2 glial cells stimulated by interferon-gamma (IFN-gamma) were co-cultured with human brain microvascular endothelial cells to investigate the effect of TMP on the BSCB disruption. Flow cytometry was used to analyze the microglia phenotype. Western blot was performed to reveal the signaling pathways involved in the microglia activation. In this study, most importantly, we found that TMP protects the BSCB integrity by modulating microglia polarization from M1 phenotype to M2 phenotype through activation of STAT3/SOCS3 and inhibition of NF-small ka, CyrillicB signaling pathways. Moreover, TMP significantly preserves the tight junction proteins, reduces the secretion of pro-inflammatory cytokines (TNF-alpha, IL-1beta) and increases the secretion of anti-inflammatory cytokines (IL-4, IL-10) from IFN-gamma-stimulated BV2 microglia cells. Consequently, protection of the BSCB integrity leads to alleviation of clinical symptoms and demyelination in EAE mice. Therefore, TMP might be an effective therapeutic agent for cerebral disorders with BBB or BSCB disruption, such as ischemic stroke, MS, and traumatic brain injury. FAU - Zhang, Lianshuang AU - Zhang L AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Lu, Xueyan AU - Lu X AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Gong, Lihua AU - Gong L AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Cui, Linlu AU - Cui L AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Zhang, Hongqin AU - Zhang H AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Zhao, Wei AU - Zhao W AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Jiang, Pengyu AU - Jiang P AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. FAU - Hou, GuiGe AU - Hou G AD - The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University, Yantai, 264003, People's Republic of China. guigehou@163.com. FAU - Hou, Yun AU - Hou Y AUID- ORCID: 0000-0001-8440-8035 AD - Department of Histology and Embryology, Binzhou Medical University, Yantai, 264003, People's Republic of China. houyun820424@163.com. LA - eng GR - 81601049/The National Natural Science Foundation of China/ GR - 21402010/The National Natural Science Foundation of China/ GR - ZR2019MB032/Nature Science Foundation of Shandong Province/ GR - 2018GSF118129/Key Research and Development Program of Shandong Province/ PT - Journal Article DEP - 20200518 PL - United States TA - Cell Mol Neurobiol JT - Cellular and molecular neurobiology JID - 8200709 RN - 0 (Cytokines) RN - 0 (NF-kappa B) RN - 0 (Pyrazines) RN - 0 (STAT3 Transcription Factor) RN - 0 (Socs3 protein, mouse) RN - 0 (Suppressor of Cytokine Signaling 3 Protein) RN - 82115-62-6 (Interferon-gamma) RN - V80F4IA5XG (tetramethylpyrazine) SB - IM MH - Animals MH - Brain/blood supply MH - *Cell Polarity/drug effects MH - Cytokines/metabolism MH - Encephalomyelitis, Autoimmune, Experimental/blood/*metabolism/pathology MH - Endothelial Cells/metabolism MH - Female MH - Humans MH - Inflammation/pathology MH - Interferon-gamma/pharmacology MH - Mice, Inbred C57BL MH - Microglia/drug effects/metabolism/*pathology MH - Microvessels/pathology MH - NF-kappa B/*metabolism MH - Neuroprotection/drug effects MH - Phenotype MH - Pyrazines/*pharmacology MH - STAT3 Transcription Factor/*metabolism MH - Signal Transduction/drug effects MH - Spinal Cord/drug effects/*pathology MH - Suppressor of Cytokine Signaling 3 Protein/*metabolism MH - Mice OTO - NOTNLM OT - Blood-spinal cord barrier OT - Experimental autoimmune encephalomyelitis OT - Microglia activation OT - Multiple sclerosis OT - Tetramethylpyrazine OT - Tight junctions EDAT- 2020/05/20 06:00 MHDA- 2021/10/07 06:00 CRDT- 2020/05/20 06:00 PHST- 2020/02/05 00:00 [received] PHST- 2020/05/12 00:00 [accepted] PHST- 2020/05/20 06:00 [pubmed] PHST- 2021/10/07 06:00 [medline] PHST- 2020/05/20 06:00 [entrez] AID - 10.1007/s10571-020-00878-3 [pii] AID - 10.1007/s10571-020-00878-3 [doi] PST - ppublish SO - Cell Mol Neurobiol. 2021 May;41(4):717-731. doi: 10.1007/s10571-020-00878-3. Epub 2020 May 18.